Patent 7264925 was granted and assigned to Avi Biopharma, Inc. on September, 2007 by the United States Patent and Trademark Office.
Disclosed are methods for separating, detecting, quantitating and/or isolating predominantly uncharged oligonucleotide analogs, by resolving duplexes of such molecules with complementary or near-complementary DNA or charged DNA analogs. The DNA or charged analog may be labeled for detection purposes.